Chemical formula: C₄H₃F₇O Molecular mass: 200.055 g/mol PubChem compound: 5206
Sevoflurane is used as an inhalational anaesthetic for induction and maintenance of general anesthesia. As with all other inhalation agents sevoflurane depresses cardiovascular function in a dose related fashion. In patients with normal intracranial pressure (ICP), sevoflurane had minimal effect on ICP and preserved CO2 responsiveness.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N01AB08 | Sevoflurane | N Nervous system → N01 Anesthetics → N01A Anesthetics, general → N01AB Halogenated hydrocarbons |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| SEVOFLURANE Inhalation Vapour, liquid | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Sevoflurane is an active ingredient of these brands:
Austria (AT)Cyprus (CY)Estonia (EE)Finland (FI)France (FR)Ireland (IE)Israel (IL)Lithuania (LT)Malta (MT)Mexico (MX)Netherlands (NL)Nigeria (NG)Romania (RO)South Africa (ZA)Spain (ES)Tunisia (TN)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
